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Abstract
Twelve angiotensin-converting enzyme (ACE) inhibitors were studied to evaluate correlation
between their absorption (ABS) data available in the literature (22–96%) and hydrophobicity param-
eters (km and Pm/w) obtained in micellar thin-layer chromatography (MTLC) using Brij 35. The theo-
retical considerations showed that the geometric molecular descriptor—volume value (Vol) should
be considered as an independent variable simultaneously with calculated hydrophobicity parame-
ters in multiple linear regression analysis to obtain reliable correlation between ACE inhibitor’s ab-
sorption and lipophilicity (calculated KOWWINlog P) and that captopril should be excluded from
further correlations. The results ofMTLC conﬁrmed that between the two hydrophobicity parameters
km and Pm/w, for absorption prediction of 11 ACE inhibitors, themicelle–water partition coefﬁcient Pm/w
provided higher correlation (R2 = 0.756), while for the km parameter R
2 = 0.612 was obtained. The
micelle–water partition coefﬁcient Pm/w could be considered as analogous to hydrophobicity param-
eter C0 from reversed-phase thin-layer chromatography. Dissimilar retention behavior of lisinopril
indicated its lowest non-polar interaction with micelle, because of its di-acid form. The proposed
model which included ACE inhibitors on the opposite site of lipophilicity—lisinopril and fosinopril
(KOWWINlog P =−0.96 and KOWWINlog P = 6.61, respectively), both with similar absorption values
(25 and 36%, respectively), could indicate that absorption of investigated compounds occurs via two
different mechanisms: active and passive transport.
Introduction
Angiotensin-converting enzyme (ACE) inhibitors are a signiﬁcant
group of drugs widely used in the treatment of hypertension and con-
gestive heart failure. Although showing similar efﬁcacy, ACE inhibi-
tors are usually classiﬁed into three different groups (those with a
sulfhydryl group—exempliﬁed by captopril, those with a carboxyl
group—exempliﬁed by enalapril and those with the phosphinic acid
group—exempliﬁed by fosinopril) and exhibit different pharmacoki-
netic characteristics (1, 2).
For oral drug absorption the molecule’s lipophilicity is the main
determinant and the most frequently used parameter in the quantitative
structure–activity relationship (QSAR) (3). Lipophilicity is character-
ized by the n-octanol/water partition coefﬁcient (logPO/W) and can be
determined by a traditional technique, the so-called shake ﬂaskmethod.
Different chromatographic methods such as liquid chromatography
(LC) or thin-layer chromatography (TLC) are well-established methods
that can yield a signiﬁcant amount of reproducible retention data for
structurally different compounds, which can be correlated with their
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physicochemical and biological properties principally lipophilicity
(4–7). Furthermore, chromatographic lipophilicity data are frequently
used in themodeling of a drug’s activity or absorption, distribution,me-
tabolism and excretion (ADME) studies. Micelle-mediated chromato-
graphic techniques are very useful in these studies. The study of
quantitative retention–structure and retention–activity relationship for
local anesthetics by micellar liquid chromatography (MLC) was pub-
lished (8). AlsoMLCwas used for prediction of drugs transport (9). Bi-
opartitioning micellar chromatography was used for modeling of
quantitative retention–activity relationship of cephalosporins (10) as
well as for prediction of oral absorption of 32 different drugs (11).
The review of biopartitioning micellar separation methods in modeling
drug absorption was also published (12). Furthermore, MLC methods
were used for modeling the quantitative retention–activity relationship
of drugs belonging to the ACE-inhibitor group (13, 14). According to
a literature survey, micellar thin-layer chromatography (MTLC) is
not as much utilized as MLC. Sumina et al. in their review paper re-
ported application of surfactants as modiﬁers in TLC (15). For iden-
tiﬁcation and quantiﬁcation of ACE inhibitor lisinopril from urine
samples (16) and for the lipophilicity study of 1,2,4-triazole (17)
and N-phenyltrichloroacetamide derivatives (18), MTLC was used.
In our previous studies, lipophilicity investigations of ﬁve ACE
inhibitors by means of reversed-phase thin-layer chromatography
(RP-TLC) (19) and salting-out thin-layer chromatography (SOTLC)
(20) were reported. Recently we established good correlation between
RP-TLC and ultra-high performance liquid chromatography–tandem
mass spectrometry (UHPLC–MS) (21) and SOTLC (22) hydrophobic-
ity data for evaluation of absorption of an extended group of ACE
inhibitors.
The aim of this study was correlation of classicalMTLC hydrophobic-
ity parameter km, the solute retention parameter at zeromicellar concentra-
tion, with calculated log P values (KOWWINlogP) for 12 investigated
ACE inhibitors. This hydrophobicity parameter (km), originally proposed
by Foley forMLC (23), was successfully applied inMTLC (17, 18). Addi-
tionally, micelle–water (Pm/w) partition coefﬁcients proposed by Tanaka
et al. (24) inMLC as well as Čudina et al. (11) was checked and evaluated
for MTLC in this study. The main topic was modeling of established
hydrophobicity parameters with literature-available absorption data in-
cluding an additional molecular descriptor as an independent variable
[aqueous solubility (log S), electronic descriptor—polar surface area
(PSA); constitutional parameter—molecular mass (Mr) and geometric
descriptor—volume value (Vol)] as well as selection of an appropriate
hydrophobicity parameter using multiple linear regression (MLR) analysis
in predicting oral drug absorption.
Experimental
Reagents and materials
The following standards of ACE inhibitors were investigated: 1. Enala-
pril maleate, (S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-
L-proline maleate (Krka Research and Development Division; Novo
Mesto, Slovenia); 2. quinapril hydrochloride, [3S-[2[R*(R*)],3R*]]-
2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl] amino]-1-oxopropyl]-1,2,
3,4-tetrahydro-3-isoquinolinecarboxylic acid hydrochloride (Hemo-
farm Stada Pharmaceutical Industry, Vrsac, Serbia); 3. fosinopril
sodium, (4S)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)-
propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline, sodium salt
(Bristol-Myers Squibb Pharmaceutical Research Institute; Princeton,
NJ, USA); 4. lisinopril dihydrate, (S)-1-[N2-(1-carboxy-3-phenylpropyl)
-L-lysyl]-L-proline dihydrate (Belupo Pharmaceutical Cosmetic Quality
Control Department, Zagreb, Croatia); 5. cilazapril monohydrate, [1S-
[1α,9α(R*)]]-9-[[1-(ethoxycarbonyl)-3-phenylpropyl] amino]octahydro
-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid monohy-
drate (Roche Pharmaceuticals; Paris, France); 6. ramipril, (2S,3aS,6aS)
-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxoprop-
yl]octahydrocyclopenta[b] pyrrole-2-carboxylic acid (Hemofarm Stada
Pharmaceutical Industry; Vrsac, Serbia); 7. benazepril hydrochloride,
(3S)-3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-
2-oxo–1H-1-benzazepine-1-acetic acid hydrochloride (EP Reference
Standard; Strasbourg, France); 8. perindopril erbumin, 2-methylpropan-
2-amine (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]
propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid (EP Ref-
erence Standard; Strasbourg, France); 9. moexipril, (3S)-2-[(2S)-2-[[(2S)-
1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-
3,4-dihydro-1H-isoquinoline-3-carboxylic acid (Tocris Bioscience in an
R and D Systems company); 10. zofenopril calcium, (2S,4R)-1-((S)-3-
(benzoylthio)-2-methylpropanoyl)-4-(phenylthio)pyrolidine-2-calcium
carboxilate (The Menarini Group, Florence, Italy), 11. trandolapril,
[2S-[1[R*(R*)],2α,3aα,7aβ]]-1-[2-[[1-(ethoxycarbonyl)-3-phenyl-
propyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid
(EP Reference Standard; Strasbourg, France); 12. captopril, (S)-1-
(3-Mercapto-2-methyl-1-oxopropyl)-L-proline (EP Reference Stan-
dard; Strasbourg, France).
Micellar thin-layer chromatography
The study of selected ACE inhibitors was performed on RP-TLC C18
plates, which are commercially available (Art. 5559, E.Merck, Germany).
The plates were spotted with 1 μL aliquots of freshly prepared ethanolic
solutions of enalapril, quinapril, fosinopril, cilazapril, ramipril, benazepril,
perindopril, moexipril, trandolapril and captopril, and aqueous solutions
of lisinopril and zofenopril (about 2 mg/mL). The mobile phase was com-
posed of 20% tetrahydrofuran (THF) and 80%phosphate buffer (pH6.8)
with addition of polyoxyethylene (23) lauryl ether, Brij 35 (Sigma-Aldrich)
in concentrations varying from 0.01 to 0.06M (above the critical micellar
concentration —CMCBRIJ35 = 9 × 10−5 M). The phosphate buffer (pH
6.8) as artiﬁcial intestinal medium was prepared according to the Interna-
tional Pharmacopoeia (25) by dissolving potassium dihydrogenphosphate
(1.700 g) and sodium hydrogenphosphate (1.765 g) (analytical grade,
Merck, Germany) in deionized water (500 mL). After development, by
the ascending technique, the detection was performed under a UV lump
(λ = 254 nm). All investigations were performed at room temperature
(25 ± 2°C).
Calculations
Microsoft Ofﬁce Excel 2003 was used for the statistical regression
analysis and for the 3D graph, OriginLab 8 software was applied by
using the option “Non-linear surface ﬁtting” and function “plane”.
The software packages used for calculation of ACE inhibitors’ molec-
ular descriptors, lipophilicity (log P values), aqueous solubility (log S),
electronic descriptor—polar surface area (PSA); constitutional
parameter—molecular mass (Mr) and geometric descriptor—volume
value (Vol) as well as textbooks used to collect human oral absorption
data of examined drugs have been cited in detail in our previously
published articles (21, 22).
Results
In this research, 12 ACE inhibitors were studied by using MTLC to
evaluate the correlation between their hydrophobicity parameters
and the literature-obtained oral absorption data. The calculated
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KOWWINlog P values varied from −0.94 to 6.61; Mr values from
217.3 to 563.7 and Vol values from 195.6 to 538.7, while oral absorp-
tion (ABS) data were in the range of 22–96% (Table I). The ACE
inhibitor’s solubility data (log S values) ranged from −4.7 to −1.7
and the PSA values from 57.6 to 132.9 Å2.
According to Janicka et al. (17) and Foley (23) in MLC the follow-
ing relationship (Equation (1)) was established between retention
parameter k· and micelle (surfactant) concentration in eluent
1
k0
¼ 1
km
þ KAM
km
½M: ð1Þ
The parameter [M] may represent either the concentration of surfac-
tant or the concentration of micelle (23) and when noting that micelle
concentration corresponds to the total surfactant concentration minus
the CMC;KAM (orKsm) is the constant describing solute–micelle bind-
ing and km is the solute retention parameter at zero micellar concentra-
tion (or k′S deﬁned as retention factor for the free solute) (17, 23, 26).
The parameters KAM and km can be evaluated from the slope and
intercept of experimental 1/k′ versus [M] relationships (23). For this
study, the retention data from MTLC were used as k′ (also noted as
k). The micellar log km parameter is considered as analogous to
obtained RM
0 in RP-TLC and different authors showed relationship
between km and log km lipophilicity descriptors with log Pvalues
(17, 18).
Micelle–water partition coefﬁcient (Pm/w) in MLC was proposed
as a useful hydrophobicity descriptor of antiplatelet agents (24) as
well as for absorption prediction of 32 drugs from different pharma-
cological groups (11). According to Čudina et al. the retention param-
eter k was represented by the following equation:
1
k
¼ b  Cm þ a; ð2Þ
where the intercept a = 1/(Ps/wΦ); slope b = (Pm/w– 1)V/(Ps/w Φ) and V
is the partial molar volume (V = 1.18 l/mol for Brij 35); Ps/w is the
partition coefﬁcient between stationary phase and water; Cm is the
concentration of micelle in the mobile phase (total surfactant concen-
tration minus CMC) and Φ is the chromatographic phase ratio (11).
The CMC of Brij 35 (9 × 10−5 M) is not of signiﬁcance for further
calculations. The values of slope (b) and intercept (a) were calculated
from the linear equation (Equation (2)) by simple regression analysis
with MTLC experimental data (Cm and k). The obtained slope and
intercept permitted calculation of Pm/w
Pm=w ¼ baV þ 1: ð3Þ
In this study, following the replacement of k values (from MLC) with
retention data obtained inMTLC, the values of intercept (a) and slope
(b) were determined from linear regression analysis between retention
data and used micelle concentration range, fromwhich Pm/w data were
calculated according to Equation (3). The obtained hydrophobicity
parameters km and Pm/w are listed in Table I.
The experimentally obtained hydrophobicity parameters km,
logkm or Pm/w were correlated with selected log P values in order to
evaluate km, log km and Pm/w data as measure of lipophilicity.
Among numerous in silico obtained log P values of ACE inhibi-
tors, in our previous studies (21, 22) the selection of KOWWINlog P
as appropriate log P was evaluated on the basis of its agreement with
chromatographic hydrophobicity parameters RM
0 or C0 obtained with
RP-TLC and SOTLC, respectively. Also, an additional approach
based on algorithm and validation for the sum of ranking differences
between numerous log P values (27) was applied for evaluation of
log P value selection in our recently published SOTLC study (22),
indicating that only four log P values (Aclog P, Xlog P2, Alog P or
KOWWINlog P) are acceptable.
In this study the value of KOWWINlog Pwas selected on the basis
of its best agreement with MTLC hydrophobicity parameters km,
log km and Pm/w. Lower values of R
2 were obtained for other three
log P values: Aclog P, Xlog P2, Alog P. Parameter km showed higher
R2 in comparison with Pm/w for selected KOWWINlog P (Table II).
The correlations between all calculated molecular descriptors and
hydrophobicity parameters km, log km and Pm/w obtained in MTLC
showed that the geometric descriptor—volume value (Vol) or consti-
tutional parameter—molecular mass (Mr) could be considered as in-
dependent variables in MLR analysis with km or Pm/w values, due to
their low correlations (R2 < 0.15), while only Mr values could be con-
sidered as independent variable with log km. In the MLR analysis
applied for modeling of ACE inhibitors’ absorption as Y values,
literature-available ABS data were used, while two independent vari-
ables were used as X values, lipophilicity values (calculated or
obtained in MTLC) Vol values as X1 or Mr values as X2. The prelim-
inary theoretical MLR analysis of all 12 studied ACE inhibitors with
application of calculated KOWWINlog P values and values of Vol or
Mr, as independent variables, indicate variable Vol value as a more
suitable descriptor for correlation between predicted and
literature-available absorption data since a higher correlation (R2 =
0.463) was obtained with Vol than with Mr (R2 = 0.417). The MLR
analysis also indicated that captopril should be excluded from further
correlations since considerably lower R2 were obtained with captopril
than after its exclusion (R2 = 0.685) for KOWWINlog P and Vol
values.
This MLR analysis of 11 ACE inhibitors, with application of Vol
values and KOWWINlog P values as independent variables, provides
the following correlation (Equation (4)) with acceptable R2 as well as
probability value (P < 0.05):
ABSpredicted ¼ 10:951 ð±3:252ÞKOWWINlogP
 0:451 ð±0:111ÞVolþ 203:291 ð±39:565Þ
n ¼ 11;R2 ¼ 0:685; S ¼ 13:841;F ¼ 8:686
ð4Þ
In further modeling, substitution of KOWWINlog P with MTLC
hydrophobicity parameters, km and Pm/w values, was evaluated. The
application of Vol and km or Pm/w values as independent variables in
MLR provides correlations (Equations (5) and (6)) with probability
value P <0.05 (Figure 1)
ABSpredicted ¼ 83:429 ð±30:037Þ km  0:306 ð±0:099ÞVol
þ 194:721 ð±43:367Þ
n ¼ 11;R2 ¼ 0:612; S ¼ 15:353; F ¼ 6:310
ð5Þ
ABSpredicted ¼ 3:513 ð±0:852ÞPm=w  0:331 ð±0:079ÞVol
þ 166:258 ð±31:055Þ
n ¼ 11;R2 ¼ 0:756; S ¼ 12:172;F ¼ 12:401
ð6Þ
The obtained correlations could be evaluated as good as proposed by
Asuero et al. (R range 0.70–0.89, which corresponds to an R2 range
0.49–0.79) (28). Figure 1 represents MLR models of an ACE inhibitor’s
predicted absorption with values of molecular descriptor Vol and km or
Pm/w hydrophobicity parameters.
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Discussion
The results of an MTLC study with Brij 35 showed that an increase of
the micelle concentration in the mobile phase led to a decrease of com-
pounds retention (with the exception of lisinopril) and that order of
retention of examined ACE inhibitors are in accordance with the
order obtained for km values. According to Ruiz-Angel et al. (29) as
well as Komsta et al. (30) compounds can be classiﬁed into three
groups, according to their elution behavior with a micellar mobile
phase: compound binding to micelles (micelles increase RF values),
non-binding compounds (no trend) and anti-binding ones (decrease
RF) (29, 30). Almost all of investigated ACE inhibitors can be consid-
ered as compounds binding to micelles (micelles increase RF values)
with the exception of lisinopril (micelles decrease RF values). Reten-
tion behavior of lisinopril could be additionally explained with the
structure of lisinopril where no ester functional group exists, hence
the lowest log P values as well as the lowest non-polar interactions
with Brij 35.
Although the application of pure micellar solutions is usual in mi-
cellar chromatography, the addition of a small amount (20%) amount
of organic solvent, THF, was needed to improve spots visualization
and to achieve adequate retention. The addition of a smaller amount
of THF (10%) provides lower values of RF and hydrophobicity
parameters, km, log km and Pm/w that could not be utilized for ACE
inhibitor absorption modeling.
The main subject of this study was to establish possible correla-
tions between MTLC hydrophobicity data, km or log km and Pm/w
values, and oral absorption data of examined ACE inhibitors. The
obtained hydrophobicity parameters km, log km or Pm/w were evaluat-
ed as measures of the lipophilicity of ACE inhibitors via their correla-
tion with selected KOWWINlog P values. Our previous RP-TLC and
SOTLC studies pointed out the signiﬁcance of MLR analysis using a
selected molecular descriptor, log S (21) or PSA (22), as an indepen-
dent variable to obtain reliable correlation between the absorption
and lipophilicity of ACE inhibitors. The preliminary MLR analysis
of all investigated ACE inhibitors indicated that the variable Vol
value can be used in addition to KOWWINlog P as a suitable descrip-
tor for correlation between predicted and literature-available absorp-
tion data as well as that captopril should be excluded from further
correlations. It can be assumed that captopril was excluded from
the proposed model since this ACE inhibitor belongs to a different
(sulfhydryl) group, with a notably lower Vol value of 195.6.
The results presented by Equations (5) and (6) and obtained using
MLR analysis after substitution of KOWWINlog P with values of
MTLC hydrophobicity parameters km and Pm/w make it obvious
that MTLC hydrophobicity parameters km or Pm/w, accompanied
with molecular descriptor Vol are closely related to ACE inhibitors
absorption data and could be considered for their absorption model-
ing. Better correlation between predicted and literature-available
oral absorption data were established for micelle–water partition
coefﬁcients Pm/w.
The micelle–water partition coefﬁcient Pm/w, previously proposed
by Čudina et al. (11) as a potential biopartitioning micellar hydropho-
bicity descriptor in prediction of oral drug absorption, was conﬁrmed
in this MTLC study. In comparison with parameter km, which was
calculated with one regression parameter, intercept, the micelle–water
partition coefﬁcient (Pm/w) was calculated using both parameters slope
and intercept of regression analysis. This indicates that the micelle–water
partition coefﬁcient Pm/w can be considered as analogous to C0 in
RP-TLC, initially introduced as a more reliable measure of lipophilicity
by Bieganowska et al. (31) and successfully applied (21, 32).
In the current study fosinopril retention behavior could be
screened due to increase of elution force (RF values were increased)
by incorporating the surfactant Brij 35 to the mobile phase. In previ-
ously proposed models for ACE inhibitors absorption evaluation
based on SOTLC (22), fosinopril was excluded due to disagreement
with “Lipinski’s rule of ﬁve” (33). In comparison with RP-TLC and
SOTLC studies, MTLC resembles more to biological barriers since
solute retention behavior, which is mostly controlled by non-polar,
dipole–dipole and proton donor–acceptor interactions (29), in a mi-
cellar system with physiological conditions (pH 6.8) could be used
to mimic drug biological partitioning similar to biopartitioning micel-
lar chromatography.
The relationship between different drugs biopartitioning processes
and chromatographic data has already been shown and thin-layer
chromatographic methods have been to be proved as suitable for
Table I. The Oral Absorption Data, Calculated Molecular Descriptors and MTLC Hydrophobicity Parameters of the Selected ACE Inhibitors
ACE inhibitor ABS AC log P Xlog P2 Alog P KOWWINlog P Vol Mr km Pm/w
1. Enalapril maleate 60 1.52 2.11 2.46 2.45 356.8 376.5 0.262 (±0.005) −4.799 (±0.484)
2. Quinapril hydrochloride 60 2.08 3.16 3.66 3.72 411.4 438.6 0.136 (±0.007) −6.727 (±1.433)
3. Fosinopril sodium 36 3.05 6.31 5.44 6.61 538.7 563.7 0.040 (±0.005) −11.769 (±4.458)
4. Lisinopril dihydrate 25 0.53 1.24 1.78 −0.94 384.4 405.5 0.668 (±0.013) 6.151 (±0.311)
5. Cilazapril monohydrate 60 0.25 2.15 2.69 2.27 392.5 417.6 0.138 (±0.008) −6.941 (±1.682)
6. Ramipril 54 2.07 2.89 3.31 3.32 396.4 416.6 0.126 (±0.005) −7.734 (±1.296)
7. Benazepril hydrochloride 37 2.09 3.28 3.73 3.5 394.8 424.5 0.112 (±0.003) −7.072 (±0.686)
8. Perindopril erbumin 70 1.58 2.58 2.73 2.59 358.3 368.5 0.289 (±0.004) −3.789 (±0.363)
9. Moexipril 22 1.87 2.72 3.62 3.36 462.4 498.6 0.206 (±0.003) −5.518 (±0.458)
10. Zofenopril calcium 96 3.83 4.07 4.02 3.94 376.1 429.6 0.070 (±0.008) −11.898 (±3.929)
11. Trandolapril 70 2.39 3.45 3.76 3.81 413.2 430.5 0.123 (±0.006) −9.443 (±1.641)
12. Captopril 65 0.90 0.64 0.75 0.84 195.6 217.3 0.286 (±0.009) −8.435 (±1.023)
Table II. The Selection of Appropriate log P Based on Correlation
Coefﬁcients for Relationships Between Experimental MTLC (km,
log km and Pm/w) and calculated (KOWWINlog P, Aclog P, Xlog P2,
Alog P) hydrophobicity parameters of the selected ACE Inhibitors
R2
KOWWINlog P Aclog P Xlog P2 Alog P
Parameter
km 0.758 0.409 0.460 0.478
log km 0.843 0.566 0.773 0.709
Pm/w 0.620 0.438 0.365 0.295
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fast and easy estimation of biological properties (34). In Sherma’s re-
view paper different planar chromatographic systems were described,
from a medicinal chemistry point of view, as useful tools capable of
simulating biological processes (35). Karelson et al. (36) developed
QSAR models for parallel artiﬁcial membrane permeability assay
(PAMPA) permeabilities (log Papp) at different pH values (pH 5.5
and 7.4). The obtained linear (multilinear regression) and non-linear
(artiﬁcial neural network) models link the drug structures to their re-
ported permeabilities. In the linear approach the best MLR provided
R2 ranging from 0.688 to 0.789, while better correlations were estab-
lished using a non-linear approach. Also, Hou et al. (37) predicted
human intestinal absorption for a set of 648 different chemical com-
pounds by correlation with several important molecular properties.
The best prediction model was established with four molecular de-
scriptors and was able to predict the absorption of all compounds
with R = 0.84 (corresponding to R2 = 0.705) while for a reduced,
98-compound test set R was 0.90 (corresponding to R2 = 0.810).
Since Hou proposed the criteria |R|≥ 0.6 for correlation between im-
portant molecular properties and intestinal absorption (37), the re-
sults obtained in our study can be considered as sufﬁciently good,
especially forMLR analysis with application of the micelle–water par-
tition coefﬁcient Pm/w with R
2 = 0.756 (corresponding to R = 0.869).
The ACE inhibitors investigated in current paper applying MTLC
included the compounds with the lowest, 22% (moexipril) and high-
est, 96% (zofenopril calcium) oral absorption. Also, according to -
Figure 1 the most hydrophilic (lisinopril dihydrate; KOWWINlog
P = −0.96) and most lipophilic (fosinopril; KOWWINlog P = 6.61)
compounds were successfully included in the proposed absorption
model and their similar (25 and 36%, respectively) absorption values
indicate that a higher extent of ACE inhibitors’ absorption proceeds
via active transport. Consequently, although the correlations obtained
in MTLC were slightly lower than previously established in SOTLC
modeling, they still should be considered as sufﬁciently reliable and
signiﬁcant. In the previous proposed model (SOTLC) established in
our study (22), fosinopril could not be included due to its highest lip-
ophilicity. The main advantage of the presentedMTLCmodel in com-
parison with our previously published SOTLC study of modeling ACE
inhibitors absorption is the applicability of the proposed model
obtained with MTLC hydrophobicity parameters on an extended
group of ACE inhibitors in which the most lipophilic (fosinopril)
could be included simultaneously with thewhole group of investigated
drugs.
Conclusion
The results of MTLC (using non-ionic surfactant Brij 35) conﬁrmed
that between two hydrophobicity parameters km or Pm/w, for absorp-
tion prediction of investigated 11 ACE inhibitors, micelle–water par-
tition coefﬁcient Pm/w provides higherR
2 (0.756) and can be evaluated
as a better MTLC parameter based on MLR analysis including the
geometric descriptor—Vol as an independent variable. Moreover,
micelle–water partition coefﬁcient Pm/w, established in the MTLC
study, could be considered as analogous to C0 in RP-TLC. The
proposed model which included compounds on the opposite site of
lipophilicity—lisinopril (KOWWINlog P =−0.96) and fosinopril
(KOWWINlog P = 6.61), both with similar absorption values (25 and
36%, respectively)—could indicate that absorption of investigated com-
pounds occurs via two different mechanisms: active as well as passive
transport.
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